Skip to content

Re-Connect Application for Smoking Cessation

Re-Connect Usability, Feasibility, Acceptability, and Preliminary Efficacy Testing

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05224154
Enrollment
9
Registered
2022-02-04
Start date
2021-12-14
Completion date
2026-02-28
Last updated
2026-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acceptability of Health Care, Nicotine Dependence, Cigarettes, Smoking Cessation

Brief summary

This series of studies will explore the acceptability, feasibility, and preliminary efficacy of making access to smartphone applications contingent on objective evidence of smoking abstinence.

Detailed description

Aim 1 will use small focus groups and feedback sessions (n = 4-6) to gain insight into the acceptability and usability of Re-Connect. Up to 3 single-case design studies (n = 4/round) will then be conducted to get more extended use of the app in a real world context to get additional information about usability and acceptability of the app. Aim 2 will involve a 2-group (AC vs SC), pilot randomized control trial to test the feasibility, acceptability, and preliminary efficacy of Re-Connect.

Interventions

BEHAVIORALAbstinent Contingent (AC) Re-Connect

Participants in this group will be able to unblock highly desired, but non-essential (e.g., social networking, shopping, games) applications contingent on meeting goals for smoking abstinence, as verified by meeting carbon monoxide goals (CO\<=6ppm).

Sponsors

Rowan University
Lead SponsorOTHER
University of Kentucky
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Aim 1 will use small focus groups and feedback sessions (n = 4-6) to gain insight into the acceptability and usability of Re-Connect. Up to 3 single-case design studies (n = 4/round) will then be conducted to get more extended use of the app in a real world context to get additional information about usability and acceptability of the app. Aim 2 will involve a 2-group (AC vs SC), pilot randomized control trial to test the feasibility, acceptability, and preliminary efficacy of Re-Connect.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* individuals who report smoking at least 10 cigarettes per day for at least 2 years, -18 years of age or older * do not have any health complications that might interfere with the study or require more intensive treatment (e.g., emphysema, chronic obstructive pulmonary disorder, asthma, lactose intolerance) * report a strong desire to quit smoking (8 or higher on a 10-point Likert scale) * has prior experience using a smartphone, speak English, and are literate, will be eligible for the study.

Exclusion criteria

* Individuals with mental health complications that are either un-managed or that have been managed for less than 6-months

Design outcomes

Primary

MeasureTime frameDescription
System Usability Surveythrough study completion, up to 12-weeksA survey that participants in Aim 1 usability testing will complete after testing out the Re-Connect application. Focus and feedback group participants, as well as single-case design participants, will complete this survey and a score of 75 or higher will be required before moving to the RCT in Aim 2.
Reconnect use (RCT, Aim 2)6-monthsOver the 6-month observation period we will track the how much and to what extent participants use Re-Connect and continue to submit CO samples.
Duration of Re-Connect Use (RCT, Aim 2)6-monthsOver the 6-month study we will track how long participants are engaged with using Re-Connect.
Acceptability (RCT, Aim 2)6-monthsAt three time points we will have the participants complete a Treatment Acceptability Questionnaire to provide quantitative and qualitative feedback on their experience with using Re-Connect.
Percent negative carbon monoxide samples6-monthsWe will compare the percentage of CO samples that meet the abstinence goals during the 6-month study.
7-day point prevalence of self-reported, and CO verified, smoking6-monthsParticipants will provide self-reports and a CO sample to confirm smoking status throughout the 6-month study.

Secondary

MeasureTime frameDescription
Initial Acceptability1 dayIndividuals who respond to our advertisement for a smoking cessation intervention will be given information about Re-Connect and then they will be given the option of continuing to participate or discontinuing. Participants who discontinue will be asked why they are not interested to inform future versions of the intervention to make it more widely acceptable and therefore more likely to be adopted by a broader population.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORBethany Raiff, PhD

Rowan University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 3, 2026